ncRNA name
BC200
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Glioma
Cancer site
qRT-PCR,Western blot
Treatment type
Chemotherapy
Drug
Temozolomide
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
the molecular mechanism of BC200 promotes GB oncogenicity and TMZ resistance through miR-218-5p expression modulation
Tissue resource
tissue samples from patients with primary and recurrent glioblastoma
human glioblastoma cell lines T98G
human glioblastoma cell lines U87MG
Experiment
None
Institute
Taipei Medical University
American Type Culture Collection
Country
China
United States
Continent
Asia
North Amercian